Bandiera C, Ng R, Mistry S, Harris E, Harris M, Aslani P
Int J Equity Health. 2025; 24(1):58.
PMID: 40022158
PMC: 11869407.
DOI: 10.1186/s12939-025-02415-4.
Bandiera C, Cardoso E, Locatelli I, Zaman K, Diciolla A, Digklia A
PLoS One. 2024; 19(6):e0304573.
PMID: 38848380
PMC: 11161104.
DOI: 10.1371/journal.pone.0304573.
Bandiera C, Dotta-Celio J, Locatelli I, Nobre D, Wuerzner G, Pruijm M
Front Pharmacol. 2024; 15:1294436.
PMID: 38327981
PMC: 10847300.
DOI: 10.3389/fphar.2024.1294436.
Bawab N, Moullin J, Jotterand S, Rossier C, Schneider M, Perraudin C
J Contin Educ Health Prof. 2023; 43(2):77-86.
PMID: 36877813
PMC: 10219666.
DOI: 10.1097/CEH.0000000000000466.
Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A
Cancers (Basel). 2023; 15(1).
PMID: 36612312
PMC: 9818079.
DOI: 10.3390/cancers15010316.
Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study.
Bandiera C, Lam L, Locatelli I, Dotta-Celio J, Duarte D, Wuerzner G
Diabetol Metab Syndr. 2022; 14(1):140.
PMID: 36167584
PMC: 9516833.
DOI: 10.1186/s13098-022-00898-7.
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
Bandiera C, Pasquier J, Locatelli I, Niquille A, Wuerzner G, Dotta-Celio J
Patient Prefer Adherence. 2022; 16:2313-2320.
PMID: 36046500
PMC: 9423122.
DOI: 10.2147/PPA.S377780.
Intensifying approaches to address clinical inertia among cardiovascular disease risk factors: A narrative review.
Lewinski A, Jazowski S, Goldstein K, Whitney C, Bosworth H, Zullig L
Patient Educ Couns. 2022; 105(12):3381-3388.
PMID: 36002348
PMC: 9675717.
DOI: 10.1016/j.pec.2022.08.005.
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Courlet P, Cardoso E, Bandiera C, Stravodimou A, Zurcher J, Chtioui H
Pharmaceutics. 2022; 14(7).
PMID: 35890213
PMC: 9322950.
DOI: 10.3390/pharmaceutics14071317.
Digital Medication Adherence Support: Could Healthcare Providers Recommend Mobile Health Apps?.
Backes C, Moyano C, Rimaud C, Bienvenu C, Schneider M
Front Med Technol. 2022; 2:616242.
PMID: 35047896
PMC: 8757821.
DOI: 10.3389/fmedt.2020.616242.
Cost-Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy.
Valverde-Merino M, Martinez-Martinez F, Garcia-Mochon L, Benrimoj S, Malet-Larrea A, Perez-Escamilla B
Patient Prefer Adherence. 2021; 15:2363-2376.
PMID: 34729007
PMC: 8554318.
DOI: 10.2147/PPA.S330371.
Communicating Electronic Adherence Data to Physicians-Consensus-Based Development of a Compact Reporting Form.
Dietrich F, Zeller A, Haag M, Hersberger K, Arnet I
Int J Environ Res Public Health. 2021; 18(19).
PMID: 34639562
PMC: 8507897.
DOI: 10.3390/ijerph181910264.
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.
Bandiera C, Cardoso E, Locatelli I, Digklia A, Zaman K, Diciolla A
JMIR Res Protoc. 2021; 10(6):e30090.
PMID: 34185020
PMC: 8278299.
DOI: 10.2196/30090.
Response to the first wave of the COVID-19 pandemic in the community pharmacy of a University Center for Primary Care and Public Health.
Bourdin A, Dotta-Celio J, Niquille A, Berger J
Res Social Adm Pharm. 2021; 18(4):2706-2710.
PMID: 34154930
PMC: 8206623.
DOI: 10.1016/j.sapharm.2021.06.010.
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS).
Bandiera C, Dotta-Celio J, Locatelli I, Nobre D, Wuerzner G, Pruijm M
JMIR Res Protoc. 2021; 10(3):e25966.
PMID: 33739292
PMC: 8088877.
DOI: 10.2196/25966.
An Adherence-Enhancing Program Increases Retention in Care in the Swiss HIV Cohort.
Kamal S, Glass T, Doco-Lecompte T, Locher S, Bugnon O, Parienti J
Open Forum Infect Dis. 2020; 7(9):ofaa323.
PMID: 32913876
PMC: 7473741.
DOI: 10.1093/ofid/ofaa323.
Implementation and Effectiveness of an Interprofessional Support Program for Patients with Type 2 Diabetes in Swiss Primary Care: A Study Protocol.
Bawab N, Moullin J, Perraudin C, Bugnon O
Pharmacy (Basel). 2020; 8(2).
PMID: 32575887
PMC: 7357028.
DOI: 10.3390/pharmacy8020106.
A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Schneider M, Achtari Jeanneret L, Chevaux B, Backes C, Wagner A, Bugnon O
Front Pharmacol. 2019; 9:1567.
PMID: 30761009
PMC: 6361826.
DOI: 10.3389/fphar.2018.01567.
Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?.
Perraudin C, Locca J, Rossier C, Bugnon O, Schneider M
BMC Health Serv Res. 2019; 19(1):15.
PMID: 30621697
PMC: 6323833.
DOI: 10.1186/s12913-018-3851-x.
Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results.
Lelubre M, Clerc O, Grosjean M, Amighi K, De Vriese C, Bugnon O
BMC Health Serv Res. 2018; 18(1):874.
PMID: 30458844
PMC: 6247756.
DOI: 10.1186/s12913-018-3641-5.